Wednesday, April 30, 2014

British Journal of Cancer - Table of Contents alert Volume 110 Issue 9

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 110, Issue 9 (2165-2388)
Published online 29 April 2014

In this issue
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology

Also new today
Advance online publication
Digital Edition

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Tumour protein predicts response to chemo in oesophageal cancer patients 

Patients with the most common type of oesophageal cancer are less likely to respond to chemotherapy when their tumours are high in a protein called leptin, according to research published in the British Journal of Cancer

Click here to read the article.

Clinical Studies

Top

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer

L Fornaro, S Cereda, G Aprile, S Di Girolamo, D Santini, N Silvestris, S Lonardi, F Leone, M Milella, C Vivaldi, C Belli, F Bergamo, S E Lutrino, R Filippi, M Russano, V Vaccaro, A E Brunetti, V Rotella, A Falcone, M A Barbera, J Corbelli, G Fasola, M Aglietta, V Zagonel, M Reni, E Vasile and G Brandi

Br J Cancer 2014 110: 2165-2169; advance online publication, April 8, 2014; 10.1038/bjc.2014.190

Abstract | Full Text

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours

F A L M Eskens, P Tresca, D Tosi, L Van Doorn, H Fontaine, A Van der Gaast, C Veyrat-Follet, C Oprea, M Hospitel and V Dieras

Br J Cancer 2014 110: 2170-2177; advance online publication, April 8, 2014; 10.1038/bjc.2014.137

Abstract | Full Text

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?

T S Maughan, A M Meade, R A Adams, S D Richman, R Butler, D Fisher, R H Wilson, B Jasani, G R Taylor, G T Williams, J R Sampson, M T Seymour, L L Nichols, S L Kenny, A Nelson, C M Sampson, E Hodgkinson, J A Bridgewater, D L Furniss, R Roy, M J Pope, J K Pope, M Parmar, P Quirke and R Kaplan

Br J Cancer 2014 110: 2178-2186; advance online publication, April 17, 2014; 10.1038/bjc.2014.182

Abstract | Full Text

Spectrum of very early breast cancer in a setting without organised screening

N Bhoo-Pathy, S Subramaniam, N A Taib, M Hartman, Z Alias, G-H Tan, R I Ibrahim, C-H Yip and H M Verkooijen

Br J Cancer 2014 110: 2187-2194; advance online publication, April 15, 2014; 10.1038/bjc.2014.183

Abstract | Full Text

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

C Daveau, S Baulies, M Lalloum, M Bollet, B Sigal-Zafrani, X Sastre, A Vincent-Salomon, A Tardivon, F Thibault, J Y Pierga, P Cottu, M P Sablin, R Rouzier, C Malhaire, P Mallon and F Reyal

Br J Cancer 2014 110: 2195-2200; advance online publication, April 8, 2014; 10.1038/bjc.2014.143

Abstract | Full Text

Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer

A G de Liaño, O Reig, B Mellado, C Martin, E U Rull and J P Maroto

Br J Cancer 2014 110: 2201-2208; advance online publication, April 10, 2014; 10.1038/bjc.2014.189

Abstract | Full Text

Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy

M I Koukourakis, A Giatromanolaki, A Bottini, M R Cappelletti, L Zanotti, G Allevi, C Strina, M Ardine, M Milani, G Brugnoli, M Martinotti, G Ferrero, R Bertoni, F Ferrozzi, A L Harris and D Generali

Br J Cancer 2014 110: 2209-2216; advance online publication, April 10, 2014; 10.1038/bjc.2014.196

Abstract | Full Text

Translational Therapeutics

Top

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy

M I Koukourakis, A Giatromanolaki, M Panteliadou, S E Pouliliou, P S Chondrou, S Mavropoulou and E Sivridis

Br J Cancer 2014 110: 2217-2223; advance online publication, April 8, 2014; 10.1038/bjc.2014.158

Abstract | Full Text

Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents

M N Saha, Y Chen, M-H Chen, G Chen and H Chang

Br J Cancer 2014 110: 2224-2231; advance online publication, April 1, 2014; 10.1038/bjc.2014.164

Abstract | Full Text

Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma

J Yamamoto, K Ohnuma, R Hatano, T Okamoto, E Komiya, H Yamazaki, S Iwata, N H Dang, K Aoe, T Kishimoto, T Yamada and C Morimoto

Br J Cancer 2014 110: 2232-2245; advance online publication, April 17, 2014; 10.1038/bjc.2014.151

Abstract | Full Text

Molecular Diagnostics

Top

Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas

N Mäkinen, H-R Heinonen, J Sjöberg, J Taipale, P Vahteristo and L A Aaltonen

Br J Cancer 2014 110: 2246-2249; advance online publication, March 18, 2014; 10.1038/bjc.2014.138

Abstract | Full Text

GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma

Y Xue, G Wu, Y Liao, G Xiao, X Ma, X Zou, G Zhang, R Xiao, X Wang, Q Liu, D Long, J Yang, H Xu, F Liu, M Liu, K Xie and R Huang

Br J Cancer 2014 110: 2250-2260; advance online publication, March 4, 2014; 10.1038/bjc.2014.124

Abstract | Full Text

High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma

H An, L Xu, Y Zhu, T Lv, W Liu, Y Liu, H Liu, L Chen, J Xu and Z Lin

Br J Cancer 2014 110: 2261-2268; advance online publication, April 8, 2014; 10.1038/bjc.2014.179

Abstract | Full Text

Ascites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine

T Golan, D Atias, I Barshack, C Avivi, R S Goldstein and R Berger

Br J Cancer 2014 110: 2269-2276; advance online publication, March 25, 2014; 10.1038/bjc.2014.123

Abstract | Full Text

Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma

M Teng, S Pirrie, D G Ward, L K Assi, R G Hughes, D Stocken and P J Johnson

Br J Cancer 2014 110: 2277-2282; advance online publication, March 6, 2014; 10.1038/bjc.2014.121

Abstract | Full Text

Notch1 activation is a poor prognostic factor in patients with gastric cancer

H Zhang, X Wang, J Xu and Y Sun

Br J Cancer 2014 110: 2283-2290; advance online publication, March 18, 2014; 10.1038/bjc.2014.135

Abstract | Full Text

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer

C Zhu, C Ren, J Han, Y Ding, J Du, N Dai, J Dai, H Ma, Z Hu, H Shen, Y Xu and G Jin

Br J Cancer 2014 110: 2291-2299; advance online publication, March 4, 2014; 10.1038/bjc.2014.119

Abstract | Full Text

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1

Y Feng, J Zhu, C Ou, Z Deng, M Chen, W Huang and L Li

Br J Cancer 2014 110: 2300-2309; advance online publication, March 18, 2014; 10.1038/bjc.2014.122

Abstract | Full Text

TAp63 suppress metastasis via miR-133b in colon cancer cells

C W Lin, X R Li, Y Zhang, G Hu, Y H Guo, J Y Zhou, J Du, L Lv, K Gao, Y Zhang and H Deng

Br J Cancer 2014 110: 2310-2320; advance online publication, March 4, 2014; 10.1038/bjc.2014.118

Abstract | Full Text

Epidemiology

Top

Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom

K E Bradbury, A Balkwill, E A Spencer, A W Roddam, G K Reeves, J Green, T J Key, V Beral, K Pirie and The Million Women Study Collaborators

Br J Cancer 2014 110: 2321-2326; advance online publication, March 27, 2014; 10.1038/bjc.2014.148

Abstract | Full Text

Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis

P Chen, C Li, X Li, J Li, R Chu and H Wang

Br J Cancer 2014 110: 2327-2338; advance online publication, March 25, 2014; 10.1038/bjc.2014.155

Abstract | Full Text

Cigarette smoking and postmenopausal breast cancer risk in a prospective cohort

S J Nyante, G L Gierach, C M Dallal, N D Freedman, Y Park, K N Danforth, A R Hollenbeck and L A Brinton

Br J Cancer 2014 110: 2339-2347; advance online publication, March 18, 2014; 10.1038/bjc.2014.132

Abstract | Full Text

Cholecystectomy, gallstones, tonsillectomy, and pancreatic cancer risk: a population-based case-control study in minnesota

J Zhang, A E Prizment, I B Dhakal and K E Anderson

Br J Cancer 2014 110: 2348-2353; advance online publication, March 25, 2014; 10.1038/bjc.2014.154

Abstract | Full Text

Paediatric head CT scan and subsequent risk of malignancy and benign brain tumour: a nation-wide population-based cohort study

W-Y Huang, C-H Muo, C-Y Lin, Y-M Jen, M-H Yang, J-C Lin, F-C Sung and C-H Kao

Br J Cancer 2014 110: 2354-2360; advance online publication, February 25, 2014; 10.1038/bjc.2014.103

Abstract | Full Text

Does cancer risk increase with HbA1c, independent of diabetes?

J C de Beer and L Liebenberg

Br J Cancer 2014 110: 2361-2368; advance online publication, March 27, 2014; 10.1038/bjc.2014.150

Abstract | Full Text

Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis

J L Petrick, A B Wyss, A M Butler, C Cummings, X Sun, C Poole, J S Smith and A F Olshan

Br J Cancer 2014 110: 2369-2377; advance online publication, March 11, 2014; 10.1038/bjc.2014.96

Abstract | Full Text

Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a meta-analysis

S Zhang, X-Q Zhang, X-W Ding, R-K Yang, S-L Huang, F Kastelein, M Bruno, X-J Yu, D Zhou and X-P Zou

Br J Cancer 2014 110: 2378-2388; advance online publication, March 20, 2014; 10.1038/bjc.2014.127

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: